News

Although diagnostic criteria for a depressive episode are the same for unipolar major depression and bipolar depression, these episodes differ in their natural history.

Are these the times that try psychiatrists’ souls?

A new transcranial direct current stimulation device received approval from the FDA for an investigational device exemption, prompting a phase 3 trial.

Digital communication is a powerful tool, but without clear boundaries, it can blur the line between education and clinical care, leading to ethical and professional challenges.

A one-size-fits-all approach does not work—each mother’s experience with postpartum depression is unique.

These words related to psychiatry are officially being banned.

The resource includes the latest research and best practices for addressing the opioid crisis with incarcerated individuals.

Dance/movement therapy has proven to be effective in treating children with trauma, making dance something that can change the way a child develops psychologically.

Psychiatry has a lot to learn from the case of Gabby Petito.

Increased awareness of catatonia and its treatment among health care providers, especially in underresourced areas, is essential for improving patient outcomes.

Today marks 5 years since the World Health Organization declared COVID-19 a pandemic. These are the psychiatric impacts.

A single dose of psilocybin was associated with a significant and sustained reduction in depressive symptoms and possible improvement of PTSD and burnout experienced by clinicians from the front line of the COVID-19 pandemic.

Do we need to be saved from empathy, as Elon Musk suggests?

A new trial is testing a first-of-its-kind stem cell therapy for Parkinson disease, using a patient’s own reprogrammed cells to restore lost dopamine function.

In a survey capturing the lived experiences of individuals with schizophrenia on antipsychotic medications, 27% of participants reported that antipsychotics had done “more harm than good.”

To be successful, telehealth visits must come as close as possible to in-person appointments. One psychiatrist shares his best practices.

Here is a message to the women all over the world who need uplifting.

Does palliative psychiatry inevitably lead to advocacy for assisted suicide?

Here are highlights from this week in Psychiatric Times, including updates on the BHV-7000 for bipolar disorder trial and a new study on physician suicide rates.

Postpartum psychosis occurs in about 1 to 2 per thousand new mothers. In this personal story, one writer shares her experience with postpartum psychosis.

Epidemiological data show that rates of anxiety, depression, self-injurious behaviors, and suicidality increased for Gen Z in significantly higher numbers than previous generations.

More power and action are needed for women—now more than ever.

Learn more about the impact birth complications and life factors may have on postpartum depression.

The impacts of this pandemic continue to ripple. All we can do is try our best to stay informed. That’s where we come in.

We want to hear from you: what ethical issues in psychiatry are you most worried about?

The revolution has been televised. Check out these 8 psychiatric perspectives on the current state of politics.

A recent study found that ketamine and transcranial magnetic stimulation show promise in treating treatment-resistant depression in older adults.

A new study found that suicidal ideation and firearm access are the strongest predictors of veteran suicide risk.

Neurocrine Biosciences has initiated a phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of NBI-1140675 for certain neurological and neuropsychiatric conditions, such as tardive dyskinesia.

Dumb idea: We should expect rates of mental illness to melt away due to widespread treatment.